Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review

Background: TNFα inhibitors are regularly used to treat autoimmune diseases. Tuberculosis (TB) and viral hepatitis B are considered potential infectious complications, and screening and surveillance are therefore recommended. Current guidelines do not take into account regional differences in endemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahnich, Nina, Arkwright, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894886/
https://www.ncbi.nlm.nih.gov/pubmed/36744250
http://dx.doi.org/10.3389/fphar.2023.1046306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894886/
https://www.ncbi.nlm.nih.gov/pubmed/36744250
http://dx.doi.org/10.3389/fphar.2023.1046306

Ejemplares similares